What are the dangers of recirculation with a graft during dialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dangers of Recirculation with Dialysis Grafts

Recirculation in a dialysis graft is dangerous because it directly causes inadequate dialysis delivery, leading to increased patient mortality and morbidity from uremic complications, and serves as a critical marker for underlying venous stenosis that will progress to graft thrombosis if left untreated. 1

Primary Mechanism of Harm: Inadequate Dialysis

  • Recirculation causes already-dialyzed blood to return to the dialyzer without passing through body tissues first, dramatically reducing dialysis efficiency 1
  • This results in the inability to achieve prescribed Kt/V targets, directly increasing patient mortality and morbidity from uremic toxin accumulation 1
  • Patients can develop insidious onset of uremic symptoms despite apparently receiving regular, uncomplicated hemodialysis sessions 2

Recirculation as a Marker for Life-Threatening Stenosis

  • Any measurable recirculation in a properly cannulated access is abnormal and indicates low access blood flow from underlying stenosis 1
  • Access recirculation >10% using urea-based methods (or >5% using nonurea-based methods) requires immediate angiographic investigation 1
  • The underlying venous stenosis that causes recirculation will progress to complete graft thrombosis if not corrected 1

Stenosis-Related Mortality Risks

  • 85-90% of arteriovenous graft thromboses are associated with venous outflow stenotic lesions 1
  • When thrombosed grafts are not evaluated for underlying stenosis, there is a >90% chance of rapid re-thrombosis 1
  • Low blood flow from stenosis increases thrombosis risk, which can lead to complete access failure requiring emergency central venous catheter placement with its associated infection risks 1

Cascade of Complications

Immediate Dialysis Inadequacy

  • Recirculation prevents achievement of adequate urea clearance even with extended treatment times 1
  • Uremic symptoms can develop "silently" without obvious access dysfunction 2
  • Patients may present with unexplained decreases in measured dialysis dose despite normal treatment parameters 1

Progressive Access Failure

  • Primary graft survival requiring intervention occurs in 77% of grafts by 12 months and 96% by 24 months 3
  • Stenosis detected after thrombosis has occurred is less responsive to therapy than pre-thrombotic stenosis (40% vs 78.9% patency at 3 months) 1
  • Delayed recognition necessitates more invasive salvage procedures with lower success rates 3

Critical Pitfalls to Avoid

  • Never use the three-needle peripheral vein method for measuring recirculation—it overestimates recirculation unpredictably due to cardiopulmonary recirculation and venovenous disequilibrium 1
  • Do not dismiss recirculation values of 10-20% as clinically insignificant—first confirm proper needle placement (arterial upstream, venous downstream), then investigate immediately if needles are correctly positioned 1
  • Reversed needle placement causes substantial recirculation (usually >20%) and must be ruled out before pursuing angiography 1

Diagnostic Algorithm When Recirculation Detected

  1. If recirculation >20%: Immediately verify correct needle placement before further workup 1
  2. If recirculation 10-20% with proper cannulation: Proceed directly to fistulography/angiography to identify stenotic lesions 1
  3. Stenosis ≥50% diameter with abnormal recirculation requires treatment with angioplasty or surgical revision 1

The NKF-K/DOQI guidelines emphasize that recirculation in a properly functioning, correctly cannulated access should be zero 1. Any deviation from this indicates compromised access blood flow that will inevitably progress to complete failure, making early detection and intervention essential for preventing the morbidity and mortality associated with inadequate dialysis and access thrombosis 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Natural history of arteriovenous grafts in hemodialysis patients.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000

Related Questions

What are the best dialysis options for a patient with a failed Arteriovenous (AV) graft and no flow?
In an adult hemodialysis patient with a left arteriovenous graft and a 1.6 × 2.6 × 6.4 cm peri‑graft fluid collection drained percutaneously yielding only thick blood without pus, how many days of intravenous antibiotic therapy are recommended?
What is the management plan for a patient with a history of renal failure or end-stage renal disease (ESRD) and dialysis, presenting with an arteriovenous graft (AVG) and no detectable bruit, along with hypertension (elevated blood pressure)?
What is the best next dialysis access option for a patient with stage renal disease (End-Stage Renal Disease (ESRD)) and mild steal syndrome after a left brachioaxillary Arteriovenous (AV) graft, with limited venous options and a functional Peritoneal Dialysis (PD) catheter?
What is the alternative vascular access approach if an Arteriovenous Fistula (AVF) is not possible for hemodialysis?
Can antibiotics be started without a urine sample in a patient with suspected urinary tract infection (UTI)?
What is an Antinuclear Antibody (ANA) reflex screen?
What is the investigation of choice for enterovirus-induced polyradiculoneuropathy?
What are the next steps for a patient with Chronic Kidney Disease (CKD) taking an Angiotensin-Converting Enzyme (ACE) inhibitor with a significant increase in serum creatinine levels?
What is the role of endoxifen in psychiatry?
How to manage buprenorphine (Suboxone) withdrawal?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.